Content about Zoonoses

March 20, 2014

The Food and Drug Administration announced the approval of Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Leishmaniasis is caused by Leishmania, a parasite transmitted to humans through sand fly bites.

SILVER SPRING, Md. — The Food and Drug Administration announced the approval of Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Leishmaniasis is caused by Leishmania, a parasite transmitted to humans through sand fly bites. It's the first FDA-approved drug to treat cutaneous or mucosal leishmaniasis.

January 20, 2014

Bayer's Advantage Multi for Dogs (imidacloprid + moxidectin) received Food and Drug Administration approval as the first-ever treatment for circulating microfilaria in heartworm-positive dogs.

SHAWNEE, Kan. — Bayer's Advantage Multi for Dogs (imidacloprid + moxidectin) received Food and Drug Administration approval as the first-ever treatment for circulating microfilaria in heartworm-positive dogs. The approval was referenced in American Heartworm Society guidelines surrounding heartworm prevention and treatment.

April 29, 2013

The risk of Lyme disease in dogs will be "extremely high" this year, an expert group has warned.

BEL AIR, Md. — The risk of Lyme disease in dogs will be "extremely high" this year, an expert group has warned.

April 19, 2013

A veterinary group in Texas is urging pet owners to protect their cats and dogs from heartworms.

AUSTIN, Texas — A veterinary group in Texas is urging pet owners to protect their cats and dogs from heartworms.

The Texas Veterinary Medical Association is marking Heartworm Awareness Month in April, warning about the ease by which mosquitoes can transmit the illness to pets.

December 17, 2012

The Food and Drug Administration has approved a new biotech drug from GlaxoSmithKline for anthrax, the drug maker said.

LONDON — The Food and Drug Administration has approved a new biotech drug from GlaxoSmithKline for anthrax, the drug maker said.

GSK announced the approval of raxibacumab for adults and children who have inhaled Bacillus anthracis. The drug is designed for combination with antibiotics and for preventing inhalational anthrax when alternative therapies aren't available. The drug is the result of a project that Human Genome Sciences, now owned by GSK, began working on in 2001 in response to terrorist anthrax attacks in the United States.

March 9, 2012

A company that makes pet drugs has launched what it calls the first generic prescription heartworm preventive medication for sale at retail pharmacies around the country.

NEW ORLEANS — A company that makes pet drugs has launched what it calls the first generic prescription heartworm preventive medication for sale at retail pharmacies around the country.

FidoPharm announced the launch of Pet Trust Plus (ivermectin and pyrantel), a generic version of Merial's Heartgard Plus. The drug is meant to prevent heartworms from developing and reaching a dog's arteries and heart.

November 9, 2011

According to the most recent consumer snapshot survey by Interclick, 42% of Americans are planning to be immunized this year.

NEW YORK — According to the most recent consumer snapshot survey by Interclick, 42% of Americans are planning to be immunized this year.

The survey, released Wednesday, explores consumer behaviors ahead of flu season, including sentiment on the shots, preferred treatment brands and where they go for the latest news on the flu.

October 20, 2011

On average, 20,000 children under the age of 5 years are hospitalized due to flu symptoms each year, the Loyola University Health System announced Thursday in a press release encouraging parents to have their children inoculated.

MAYWOOD, Ill. — On average, 20,000 children under the age of 5 years are hospitalized due to flu symptoms each year, the Loyola University Health System announced Thursday in a press release encouraging parents to have their children inoculated.

October 11, 2011

The typical flu season always coincides with the busiest travel period of the year, and last season that spelled trouble for more than 3 million U.S. vacationers whose trips were interrupted by flu-related illness, according to the Walgreens Flu Impact Report released Tuesday.

DEERFIELD, Ill. — The typical flu season always coincides with the busiest travel period of the year, and last season that spelled trouble for more than 3 million U.S. vacationers whose trips were interrupted by flu-related illness, according to the "Walgreens Flu Impact Report" released Tuesday.

The findings in part two of the survey examining the effects of influenza on people's everyday lives, released today, showed how the flu affected Americans' vacations, holidays, social engagements, sporting events and more.